Steven McAllister

2016

In 2016, Steven McAllister earned a total compensation of $389.5K as Chief Financial Officer at InVivo Therapeutics Holdings, a 54% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$60,654
Salary$311,993
Other$16,864
Total$389,511

McAllister received $312K in salary, accounting for 80% of the total pay in 2016.

McAllister also received $60.7K in non-equity incentive plan and $16.9K in other compensation.

Rankings

In 2016, Steven McAllister's compensation ranked 12,012th out of 14,075 executives tracked by ExecPay. In other words, McAllister earned more than 14.7% of executives.

ClassificationRankingPercentile
All
12,012
out of 14,075
15th
Division
Manufacturing
4,703
out of 5,489
14th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
663
out of 827
20th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
402
out of 510
21st
Industry
Surgical and Medical Instruments and Apparatus
246
out of 313
21st
Source: SEC filing on April 25, 2017.

McAllister's colleagues

We found six more compensation records of executives who worked with Steven McAllister at InVivo Therapeutics Holdings in 2016.

2016

Pamela Stahl

InVivo Therapeutics Holdings

Chief Commercial Officer

2016

Mark Perrin

InVivo Therapeutics Holdings

Chief Executive Officer

2016

Christopher McNulty

InVivo Therapeutics Holdings

Chief Financial Officer

2016

Thomas Ulich

InVivo Therapeutics Holdings

Chief Scientific Officer

2016

Lorianne Masuoka

InVivo Therapeutics Holdings

Chief Medical Officer

2016

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

You may also like